Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Vectura to develop digitally-connected inhalers

Will collaborate with Propeller Health on sensor-enabled devices

Propeller Health digital sensor asthma COPD 

Vectura is working on a range of digitally-connected inhalers to help patients with respiratory diseases more engaged with their care.

It is collaborating with Propeller Health on the devices, which it also hopes will better equip patients to understand their disease and improve self-management.

The new inhalers will combine elements of Vectura's GyroHaler with an FDA-approved add-on senor from Propeller health (whose technology is pictured).

The companies are also discussing additional connected strategies for other proprietary respiratory devices in Vectura's pipeline.

James Ward-Lilley CEO, Vectura, said: “Adherence to therapy is one of the major issues driving poor maintenance management of these chronic conditions. 

“There is increasing evidence of the value of intelligent sensor technology significantly enabling a reduction of symptoms, including exacerbations and long term healthcare utilisation costs. This collaboration is a first step towards Vectura embracing a connected solution for all our devices.”

Propeller's digital health platform for asthma and chronic obstructive pulmonary disease (COPD) is currently used by more than 40 leading healthcare organisations across the US.

David Van Sickle, CEO, Propeller Health, said: “Digital health has the potential to make respiratory therapies more personal, powerful and convenient for every patient. We are excited to work with the team at Vectura to realize these benefits in a new generation of inhalers”

The firm's existing pharma deals include one with Boehringer Ingelheim, which it signed earlier this year and which targets adherence and care management for people living with asthma and COPD.

26th May 2016

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics